SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-289107
Filing Date
2022-11-18
Accepted
2022-11-18 17:06:05
Documents
17
Period of Report
2022-11-15
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d411326d8k.htm   iXBRL 8-K 31912
2 EX-1.1 d411326dex11.htm EX-1.1 171204
3 EX-5.1 d411326dex51.htm EX-5.1 4293
4 EX-99.1 d411326dex991.htm EX-99.1 5220
9 GRAPHIC g411326g44l21.jpg GRAPHIC 5865
  Complete submission text file 0001193125-22-289107.txt   435587

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA dna-20221115.xsd EX-101.SCH 3893
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dna-20221115_def.xml EX-101.DEF 14042
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE dna-20221115_lab.xml EX-101.LAB 23304
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dna-20221115_pre.xml EX-101.PRE 15074
11 EXTRACTED XBRL INSTANCE DOCUMENT d411326d8k_htm.xml XML 5410
Mailing Address 27 DRYDOCK AVENUE 8TH FLOOR BOSTON MA 02210
Business Address 27 DRYDOCK AVENUE 8TH FLOOR BOSTON MA 02210 (877) 442-5362
Ginkgo Bioworks Holdings, Inc. (Filer) CIK: 0001830214 (see all company filings)

IRS No.: 872652913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40097 | Film No.: 221402711
SIC: 2836 Biological Products, (No Diagnostic Substances)